Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-020159

General Counsel sold 587 shares at $6.45 ($3,784)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Martin General Counsel 2025-05-20 Sale −587 $6.45 $3,784 149,163 D: show line 1 in the form
Open-market sales · 587 sh · avg $6.45 · $3,784
Loading xslF345X05/form4.xml…